PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis
PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic
1 other identifier
observational
661
1 country
1
Brief Summary
To determine if there is a need for further education on vaccines with psoriasis patients who are on a biologic. In regards to the COVID-19, it is important that psoriasis patients - whether on a biologic or not - understand whether they can have certain vaccines. That will depend on the type of vaccine that becomes available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2020
CompletedStudy Start
First participant enrolled
August 13, 2020
CompletedFirst Posted
Study publicly available on registry
August 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 6, 2020
CompletedOctober 8, 2020
October 1, 2020
1 month
August 12, 2020
October 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients not understanding the interaction of vaccines and their biologic, assessed with voluntary survey.
Assessment is based upon survey responses. By answering multiple questions we will determine if more education is needed based on the answers.
Data will be collected over a span of 3 months
Study Arms (2)
Control
Psoriasis patients treated with non-biologic
Non-Control
Psoriasis patients treated with biologic
Eligibility Criteria
Dermatology Clinic
You may qualify if:
- psoriasis patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dermatrials Research
Hamilton, Ontario, L8N 1V6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Clinical Professor, Division of Dermatology MD FRCPC
Study Record Dates
First Submitted
August 12, 2020
First Posted
August 14, 2020
Study Start
August 13, 2020
Primary Completion
September 13, 2020
Study Completion
October 6, 2020
Last Updated
October 8, 2020
Record last verified: 2020-10